808 related articles for article (PubMed ID: 35183252)
21. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
Shi L; Gu H
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
[TBL] [Abstract][Full Text] [Related]
22. The Role of Antigen Presentation in Tumor-Associated Macrophages.
Stopforth RJ; Ward ES
Crit Rev Immunol; 2020; 40(3):205-224. PubMed ID: 33389885
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
24. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
25. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
26. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
27. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors.
Fan J; Zhu J; Zhu H; Xu H
Crit Rev Oncol Hematol; 2024 Jun; 198():104362. PubMed ID: 38614267
[TBL] [Abstract][Full Text] [Related]
28. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; BrĂ¼ne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.
Li C; Xu X; Wei S; Jiang P; Xue L; Wang J;
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33504575
[TBL] [Abstract][Full Text] [Related]
30. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophages: implications in cancer immunotherapy.
Petty AJ; Yang Y
Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC
Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300
[TBL] [Abstract][Full Text] [Related]
33. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
34. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
Rodriguez-Garcia A; Lynn RC; Poussin M; Eiva MA; Shaw LC; O'Connor RS; Minutolo NG; Casado-Medrano V; Lopez G; Matsuyama T; Powell DJ
Nat Commun; 2021 Feb; 12(1):877. PubMed ID: 33563975
[TBL] [Abstract][Full Text] [Related]
35. Tackling TAMs for Cancer Immunotherapy: It's Nano Time.
Yang Y; Guo J; Huang L
Trends Pharmacol Sci; 2020 Oct; 41(10):701-714. PubMed ID: 32946772
[TBL] [Abstract][Full Text] [Related]
36. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
[TBL] [Abstract][Full Text] [Related]
37. Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages.
Santoni M; Massari F; Montironi R; Battelli N
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188547. PubMed ID: 33932561
[TBL] [Abstract][Full Text] [Related]
38. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in Nanoimmunotherapy by Modulating Tumor-Associated Macrophages for Cancer Therapy.
Hao J; Zhao X; Wang C; Cao X; Liu Y
Bioconjug Chem; 2024 Jun; ():. PubMed ID: 38919067
[TBL] [Abstract][Full Text] [Related]
40. [Prevention and treatment of lung cancer by regulating tumor-associated macrophages with traditional Chinese medicine].
Lian YF; Yang HT; Sun Y; Zhang H; Mei X; Feng L; Xia JC
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2000-2009. PubMed ID: 37282890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]